Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

MARA

Financiado

Molecular Analytical Robotics Assays

Diagnostic tests are essential to provide a targeted treatment of infectious diseases and to contain the further spread of multidrug resistant pathogens. Current methods are based either on cultivation or on PCR and have significa... ver más

31/08/2020

AIT

4M€

Presupuesto del proyecto: 4M€

Líder del proyecto

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 7 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-08-31

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

FETOPEN-RIA-2014-2015: FET-Open research projects

I+D

Cerrada hace 10 años

0% 100%

7 Participantes

AIT

1.65M€ | Lider

TRANSPORTES CONTINUOS INTERI...

Pure Biologics S.A.

570.00K€ | Participante

548.46K€ | Participante

Proyectos interesantes

RAPP-ID Development of RApid Point-of-Care test Platforms for Infect... 16M€ Cerrado

PTQ-15-07422 Nuevos ensayos de PCR para la detección rápida y eficaz de g... 84K€ Cerrado

TEC2009-10114 ESTACION ROBOTIZADA DE BIOCARACTERIZACION: OPTIMIZACION DEL... 242K€ Cerrado

PTQ2020-011250 Desarrollo de un método de extracción de ácidos nucleicos un... 27K€ Cerrado

PTQ-14-07159 FasterPCR, Fast automated diagnostic system targeting severe... 66K€ Cerrado

FIEC13-3E-2657 DOTACIÓN A LA UNIDAD DE APOYO A LA INVESTIGACIÓN DEL HCUV DE... 110K€ Cerrado

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 57 meses Fecha Inicio: 2015-11-03
Fecha Fin: 2020-08-31

Líder del proyecto

AIT AUSTRIAN INSTITUTE OF TECHNOLOGY GMBH

TRL 4-5

Presupuesto del proyecto 4M€

Descripción del proyecto Diagnostic tests are essential to provide a targeted treatment of infectious diseases and to contain the further spread of multidrug resistant pathogens. Current methods are based either on cultivation or on PCR and have significant limitations concerning the clinical requirements to characterise pathogens including their resistance mechanisms within 3 hours. In MARA, we will develop and combine three radically novel technologies that will lead to substantial breakthroughs in science, medicine and industry and, as proof-of principle, use them to create a DNA-based molecular toolkit characterising pathogens. First, the detection of pathogen-associated antigens will be performed by Autonomous Detection Nucleic Acids (AUDENA) that are independent of any laboratory instruments and sophisticated processing. The realisation of the AUDENA concept will lead to an autonomous, stable, simple and very economic novel sensor class applicable for any water-soluble substances. The second revolutionary technology in MARA employs a novel approach in protein mimicry and creation of artificial enzymes, which represents a breakthrough in several disciplines, such as biotechnology, biomedical manufacturing and the energy sector. The third breakthrough in this project represents the development of a Molecular Robot (MORO) that can specifically identify target cells and destroy them. In MARA, the MORO will be used for the lysis of bacterial cells to release intracellular antibiotic resistance associated antigens, but the long-term vision anticipates an application as antibiotic replacement for infectious diseases and a therapeutic agent for cancer treatment, which would represent one of the most important breakthroughs in medicine in the recent years. To meet the highly ambitious objectives pointed out in this proposal, MARA is driven by a complementary, multidisciplinary team of leading experts, with a young, high-profile scientist in the lead.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores